Category Archives: Hormone Replacement Therapy

Hormone Replacement Therapy Wellington Florida By: Brian Tully … Continue reading →

By Daniela Dadurian, M.D. Question: What can I do for menopausal symptoms? Answer: For many women, menopause signifies much more than the end of menstruation and their childbearing years. It all too often raises fears of aging and drastic changes in physical and emotional well-being. Many women enter this stage of their life feeling ill-prepared to combat these changes. Perimenopause (the transition to menopause) and menopause represent the decline in hormone production as the ovaries cease regular monthly egg release (ovulation). As a result, women may experience to varying degrees many changes, including, but not limited to, hot flashes, night sweats, weight changes, skin and vaginal dryness, mood changes, bladder changes (symptoms of infection or leakage) and sleep disturbance. While these changes may be overwhelming, there are many positive steps one can take to help ease these symptoms. These include exercise; smoking cessation; healthy diet; vitamins and supplements; maintaining ideal weight; and medications, including hormone replacement. Hormone replacement therapy has been a controversial subject in the past, with concerns about safety and efficacy. However, in recent years, a more personalized and natural approach using bio-identical hormones has helped many women ease into menopause relatively seamlessly. With individualized testing and close … Continue reading →

Change Your Life By Changing Your Diet By: TheDrMatar … Continue reading →

The Women's Health Initiative (WHI) was a major 15-year research program to address the most common causes of death, disability and poor quality of life in postmenopausal women cardiovascular disease, cancer, and osteoporosis. The WHI was launched in 1991 and consisted of a set of clinical trials and an observational study, which together involved 161,808 generally healthy postmenopausal women. The clinical trials were designed to test the effects of postmenopausal hormone therapy, diet modification, and calcium and vitamin D supplements on heart disease, fractures, and breast and colorectal cancer. The hormone trial had two studies: the estrogen-plus-progestin study of women with a uterus and the estrogen-alone study of women without a uterus. (Women with a uterus were given progestin in combination with estrogen, a practice known to prevent endometrial cancer.) In both hormone therapy studies, women were randomly assigned to either the hormone medication being studied or to placebo. Those studies have now ended and the data has been analyzed. Though it was found and generally agreed upon that women who took combined hormone replacement therapy (estrogen and progesterone) to lessen their hot flushes and insomnia symptoms increased their chances of breast cancer slightly, many studies suggested that the cancer … Continue reading →

You are here: Latest News Hormone Therapy Linked to Breast Cancer Women given estrogen plus progestin -- hormone replacement therapy -- have a greater chance of contracting breast cancer, U.S. researchers say. Dr. Rowan T. Chlebowski of the Los Angeles Biomedical Research Institute, the lead researcher, and colleagues looked at postmenopausal women with no prior hysterectomy with negative mammograms within two years. The study, published in the Journal of the National Cancer Institute, found breast cancer incidence was higher in women prescribed estrogen and progestin combined therapy than those where not. Women who started hormone therapy closer to menopause had a higher breast cancer risk with a weakening influence as the time from menopause increased, the study said. "Because survival after breast cancer diagnosis did not differ between estrogen plus progestin users and non-users, the higher breast cancer incidence of those using estrogen plus progestin may lead to increased breast cancer mortality on a population basis," the authors wrote in the study. Copyright 1997 - 2013 ThirdAge Media, LLC. All rights reserved. Originally posted here: Hormone Therapy Linked to Breast Cancer … Continue reading →

FRIDAY, March 29 (HealthDay News) -- It might be possible to create artificial ovaries in the laboratory to provide a more natural form of hormone replacement therapy (HRT) for women, researchers report. As well as producing eggs, ovaries secrete hormones that are important for bone and heart health. Production of these hormones stops due to menopause, as well as surgical removal of the ovaries, chemotherapy and radiation treatments for certain types of cancer. There are hormone replacement medications, but long-term use of the drugs is generally avoided due to the increased risk of heart disease and breast cancer, according to the authors of a new study published in the March issue of the journal Biomaterials. In this study, a team from the Institute of Regenerative Medicine at Wake Forest Baptist Medical Center reported that ovaries created in the lab showed sustained release of the female sex hormones estrogen and progesterone. "Our goal is to develop a tissue- or cell-based hormone therapy -- essentially an artificial ovary -- to deliver sex hormones in a more natural manner than drugs," study senior author Emmanuel Opara, a professor of regenerative medicine, said in a Wake Forest news release. "A bioartificial ovary has the … Continue reading →

In the nearly 11 years since researchers first rang alarm bells that women on hormone replacement therapy faced an increased risk of breast cancer, some have suggested that taking estrogen and progestin to treat symptoms of menopause might not be so dangerous after all. Though it was generally agreed that woman who took the two hormones to curb their hot flashes and night sweats upped their chances of developing the disease, many studies suggested that the cancers the women developed were less likely to be deadly. A new analysis of data from the Women's Health Initiative now casts doubt on those findings. The study, published Friday by the Journal of the National Cancer Institute, concludes that the prognosis for cancers related to hormone replacement therapy is just as dire as for other breast cancers. As a result, women who turn to the treatment are more likely to die of breast cancer than their peers who don't take hormones. "You could fill a basketball arena with the women who get the disease," said Dr. Rowan Chlebowski, the principal investigator for the Women's Health Initiative and lead author of the new study. "It seems like you'd want to reach a higher threshold … Continue reading →

1:00 AM A new study debunks the notion that taking hormones for menopause is not very dangerous. Los Angeles Times LOS ANGELES In the nearly 11 years since researchers first rang alarm bells that women on hormone replacement therapy faced an increased risk of breast cancer, some have suggested that taking estrogen and progestin to treat symptoms of menopause might not be so dangerous after all. Though it was generally agreed that women who took the two hormones to curb their hot flashes and night sweats upped their chances of developing the disease, many studies suggested that the cancers the women developed were less likely to be deadly. A new analysis of data from the Women's Health Initiative now casts doubt on those findings. The study, published Friday by the Journal of the National Cancer Institute, concludes that the prognosis for cancers related to hormone replacement therapy is just as dire as for other breast cancers. As a result, women who turn to the treatment are more likely to die of breast cancer than their non-hormone-taking peers. "You could fill a basketball arena with the women who get the disease," said Dr. Rowan Chlebowski, the principal investigator for the Women's … Continue reading →

Published: March. 31, 2013 at 7:43 PM LOS ANGELES, March 31 (UPI) -- Women given estrogen plus progestin -- hormone replacement therapy -- have a greater chance of contracting breast cancer, U.S. researchers say. Dr. Rowan T. Chlebowski of the Los Angeles Biomedical Research Institute, the lead researcher, and colleagues looked at postmenopausal women with no prior hysterectomy with negative mammograms within two years. The study, published in the Journal of the National Cancer Institute, found breast cancer incidence was higher in women prescribed estrogen and progestin combined therapy than those where not. Women who started hormone therapy closer to menopause had a higher breast cancer risk with a weakening influence as the time from menopause increased, the study said. "Because survival after breast cancer diagnosis did not differ between estrogen plus progestin users and non-users, the higher breast cancer incidence of those using estrogen plus progestin may lead to increased breast cancer mortality on a population basis," the authors wrote in the study. View original post here: Hormone therapy linked to cancer … Continue reading →

Women who undergo hormone-replacement therapy (HRT) to treat symptoms of menopause are at increased risk of developing all categories of breast cancer, a new study has found. In the study, postmenopausal women on hormone replacement therapy that included both estrogen and progestin were 1.5 times more likely to develop breast cancer over an 11-year period compared with women not on the hormones. HRT increased the risk of breast cancers that have a low risk of recurrence, such as estrogen-receptor-positive cancers, as well as the risk of more aggressive breast cancers, such as triple-negative breast cancer. The findings back up the results of a study published last year that suggested HRT increased the risk of all categories of breast cancer. Before that study, doctors thought that HRT only increased the risk of less-serious cancers, said study researcher Dr. Rowan Chlebowski, of the Los Angeles Biomedical Research Institute. The new findings lead to more of a consensus on the link between HRT and breast cancer, and suggest doctors should exercise even more caution when prescribing the treatment, Chlebowski said. The decision to start HRT should be made on a case-by-case basis, Chlebowski said. Women should speak with their doctors about the risks … Continue reading →